Thus, it is reasonable to conclude that reduced APOE expression in the brain or blood of subjects lacking ε4 does not increase AD risk or that the influence of rs405509 genotype on expression of APOE is even greater among subjects who are APOE ε4/ε4. The gene discussed is APOE; the disease is Alzheimer disease.